It's an interesting argument, because I think we already have this reverse onus. Industry has to provide an information set, a data set, to the government to be reviewed. We are providing that data and that information and the test to support substances being new to the market and also being continued in the market. So I think the burden of proof is on us to provide that, and then ultimately the decision is made by the government to say “Yes, that data does meet the requirements, and yes, we will allow that substance in,” or “Yes, we will continue to allow that substance.”
On November 20th, 2006. See this statement in context.